Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Title
Intervention Indication Therapeutic Area Year Actions
Durvalumab with gemcitabine-cisplatin neoadjuvant treatment and durvalumab adjuvant treatment for muscle-invasive bladder cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Bladder cancer Urological Cancer 2022 View  |  Download
Durvalumab with platinum-based chemotherapy for the neoadjuvant/adjuvant treatment of resectable non-small-cell lung cancer Chemotherapy , Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Durvalumab with transarterial chemoembolisation for hepatocellular carcinoma Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Transarterial Chemoembolisation (TACE) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2022 View  |  Download
Durvalumab with tremelimumab for limited stage small-cell lung cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) , Tremelimumab (CP-675206; CP-675 206) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2022 View  |  Download
Duvelisib for treating relapsed and/or refractory peripheral T-cell lymphoma Duvelisib (ABBV-954; INK-1197; IPI-145; Copiktra) Peripheral T-cell lymphoma (PTCL) Haematological Cancer and Lymphomas 2022 View  |  Download
Efanesoctocog alfa for treating and preventing bleeding in people with haemophilia A who have been previously treated Efanesoctocog alfa Haemophilia A Haematology 2022 View  |  Download
Elacestrant for treating HER2-negative, ER-positive, advanced breast cancer after endocrine therapy Elacestrant Breast cancer Breast Cancer 2022 View  |  Download
Empagliflozin for the treatment of acute myocardial infarction to reduce heart failure and mortality Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2022 View  |  Download
Empagliflozin for treating chronic kidney disease Empagliflozin (Jardiance; DINAMO) Chronic kidney disease (CKD) Cardiovascular System , Nephrology 2022 View  |  Download
Empagliflozin with linagliptin for treating type 2 diabetes mellitus in children and adolescents Empagliflozin (Jardiance; DINAMO) , Linagliptin Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
1 2 5 6 7 8 9 19 20
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications